• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

May 2007: Additions and Deletions to the Drug Product List

27th Edition: Cumulative Supplement Number 5

Prescription     OTC

NOTE: The format for the Monthly Additions/Deletions Drug Product List changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section  1.6 Cumulative Supplement Legend.


ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
         ACETAMINOPHEN; HYDROCODONE BITARTRATE
          TABLET; ORAL
            HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>D>   AA      UCB INC                    500MG;10MG                              N40210 001  Aug 13, 1997    May  DISC
>A>         @                            500MG;10MG                              N40210 001  Aug 13, 1997    May  DISC
>D>   AA                                 650MG;7.5MG                             N40134 001  Nov 21, 1996    May  DISC
>A>         @                            650MG;7.5MG                             N40134 001  Nov 21, 1996    May  DISC
        ACETAZOLAMIDE
          CAPSULE, EXTENDED RELEASE; ORAL
            DIAMOX
>D>         @ DURAMED PHARMS             500MG                                   N12945 001                  May  CMFD
>A>       +                              500MG                                   N12945 001                  May  CMFD

        ALBUTEROL SULFATE
          SOLUTION; INHALATION
            ALBUTEROL SULFATE
>D>   AN      ROXANE                     EQ 0.083% BASE                          N75129 001  Feb 13, 2001    May  DISC
>A>         @                            EQ 0.083% BASE                          N75129 001  Feb 13, 2001    May  DISC

        ALLOPURINOL SODIUM
          INJECTABLE; INJECTION
            ALOPRIM
>A>   AP  +   BIONICHE PHARMA            EQ 500MG BASE/VIAL                      N20298 001  May 17, 1996    May  CAHN
>D>   AP  +   NABI                       EQ 500MG BASE/VIAL                      N20298 001  May 17, 1996    May  CAHN

        ALPRAZOLAM
          TABLET, EXTENDED RELEASE; ORAL
            ALPRAZOLAM
>A>   AB      IMPAX LABS                 0.5MG                                   N77968 004  May 24, 2007    May  NEWA
>A>   AB                                 1MG                                     N77968 003  May 24, 2007    May  NEWA
>A>   AB                                 2MG                                     N77968 002  May 24, 2007    May  NEWA
>A>   AB                                 3MG                                     N77968 001  May 24, 2007    May  NEWA

        AMIODARONE HYDROCHLORIDE
          INJECTABLE; INJECTION
>D>         CORDARONE
>D>   AP  +   WYETH PHARMS               50MG/ML                                 N20377 001  Aug 03, 1995    May  DISC
>A>         @                            50MG/ML                                 N20377 001  Aug 03, 1995    May  DISC

        AMLODIPINE BESYLATE
          TABLET; ORAL
            AMLODIPINE BESYLATE
>A>   AB      APOTEX                     EQ 2.5MG BASE                           N76719 001  May 23, 2007    May  NEWA
>A>   AB                                 EQ 5MG BASE                             N76719 002  May 23, 2007    May  NEWA
>A>   AB                                 EQ 10MG BASE                            N76719 003  May 23, 2007    May  NEWA

        AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
          CAPSULE; ORAL
>A>         AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
>A>   AB      TEVA PHARMS                EQ 2.5MG BASE;10MG                      N77179 001  May 18, 2007    May  NEWA
>A>   AB                                 EQ 5MG BASE;10MG                        N77179 002  May 18, 2007    May  NEWA
>A>   AB                                 EQ 5MG BASE;20MG                        N77179 003  May 18, 2007    May  NEWA
>A>   AB                                 EQ 10MG BASE;20MG                       N77179 004  May 18, 2007    May  NEWA
            LOTREL
>D>           NOVARTIS                   EQ 2.5MG BASE;10MG                      N20364 002  Mar 03, 1995    May  CFTG
>A>   AB                                 EQ 2.5MG BASE;10MG                      N20364 002  Mar 03, 1995    May  CFTG
>D>                                      EQ 5MG BASE;10MG                        N20364 003  Mar 03, 1995    May  CFTG
>A>   AB                                 EQ 5MG BASE;10MG                        N20364 003  Mar 03, 1995    May  CFTG
>D>                                      EQ 5MG BASE;20MG                        N20364 004  Mar 03, 1995    May  CFTG
>A>   AB                                 EQ 5MG BASE;20MG                        N20364 004  Mar 03, 1995    May  CFTG
>D>                                      EQ 10MG BASE;20MG                       N20364 005  Jun 20, 2002    May  CFTG
>A>   AB                                 EQ 10MG BASE;20MG                       N20364 005  Jun 20, 2002    May  CFTG

        AMOXICILLIN
          CAPSULE; ORAL
>D>         TRIMOX
>D>   AB      APOTHECON                  250MG                                   N61885 001                  May  DISC
>A>         @                            250MG                                   N61885 001                  May  DISC
>D>   AB                                 500MG                                   N61885 002                  May  DISC
>A>         @                            500MG                                   N61885 002                  May  DISC

        AZACITIDINE
>A>       INJECTABLE; IV-SC
>A>         VIDAZA
>A>       +   PHARMION                   100MG/VIAL                              N50794 001  May 19, 2004    May  CDFR
>D>       INJECTABLE; SUBCUTANEOUS
>D>         VIDAZA
>D>       +   PHARMION                   100MG/VIAL                              N50794 001  May 19, 2004    May  CDFR

        AZITHROMYCIN
          INJECTABLE; INJECTION
            AZITHROMYCIN
>D>   AP  +   SICOR PHARMS               EQ 500MG BASE/VIAL                      N50809 001  Dec 19, 2006    May  CAHN
>D>       +                              EQ 2.5GM BASE/VIAL                      N50809 002  Dec 19, 2006    May  CAHN
>A>   AP  +   TEVA PARENTERAL            EQ 500MG BASE/VIAL                      N50809 001  Dec 19, 2006    May  CAHN
>A>       +                              EQ 2.5GM BASE/VIAL                      N50809 002  Dec 19, 2006    May  CAHN
          SOLUTION/DROPS; OPHTHALMIC
            AZASITE
>D>       +   INSITE VISION              1%                                      N50810 001  Apr 27, 2007    May  CAHN
>A>       +   INSPIRE                    1%                                      N50810 001  Apr 27, 2007    May  CAHN
          TABLET; ORAL
            AZITHROMYCIN
>A>   AB      MYLAN                      EQ 250MG BASE                           N65365 001  May 30, 2007    May  NEWA
>A>   AB                                 EQ 500MG BASE                           N65366 001  May 30, 2007    May  NEWA

        BETAMETHASONE DIPROPIONATE
          LOTION, AUGMENTED; TOPICAL
>A>         BETAMETHASONE DIPROPIONATE
>A>   AB      ALTANA                     EQ 0.05% BASE                           N77111 001  May 21, 2007    May  NEWA
>A>   AB      TARO                       EQ 0.05% BASE                           N77477 001  May 21, 2007    May  NEWA
            DIPROLENE
>D>       +   SCHERING                   EQ 0.05% BASE                           N19716 001  Aug 01, 1988    May  CFTG
>A>   AB  +                              EQ 0.05% BASE                           N19716 001  Aug 01, 1988    May  CFTG

>D>     BISKALCITRATE; METRONIDAZOLE; TETRACYCLINE
>D>       CAPSULE; ORAL
>D>         PYLERA
>D>       +   AXCAN                      140MG;125MG;125MG                       N50786 001  Sep 28, 2006    May  CAIN

>A>     BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE
>A>       CAPSULE; ORAL
>A>         PYLERA
>A>       +   AXCAN                      140MG;125MG;125MG                       N50786 001  Sep 28, 2006    May  CAIN

        BUPIVACAINE HYDROCHLORIDE
          INJECTABLE; INJECTION
            SENSORCAINE
>A>   AP      ABRAXIS                    0.25%                                   N70552 001  May 21, 1986    May  CAHN
>A>   AP                                 0.25%                                   N18304 001                  May  CAHN
>A>   AP                                 0.5%                                    N70553 001  May 21, 1986    May  CAHN
>A>   AP                                 0.5%                                    N18304 002                  May  CAHN
>A>   AP                                 0.75%                                   N70554 001  May 21, 1986    May  CAHN
>A>   AP                                 0.75%                                   N18304 003                  May  CAHN
>D>   AP      ASTRAZENECA                0.25%                                   N70552 001  May 21, 1986    May  CAHN
>D>   AP                                 0.25%                                   N18304 001                  May  CAHN
>D>   AP                                 0.5%                                    N70553 001  May 21, 1986    May  CAHN
>D>   AP                                 0.5%                                    N18304 002                  May  CAHN
>D>   AP                                 0.75%                                   N70554 001  May 21, 1986    May  CAHN
>D>   AP                                 0.75%                                   N18304 003                  May  CAHN
          INJECTABLE; SPINAL
            SENSORCAINE
>A>   AP      ABRAXIS                    0.75%                                   N71202 001  Apr 15, 1987    May  CAHN
>D>   AP      ASTRAZENECA                0.75%                                   N71202 001  Apr 15, 1987    May  CAHN

        BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
          INJECTABLE; INJECTION
            SENSORCAINE
>A>   AP      ABRAXIS                    0.25%;0.0091MG/ML                       N70967 001  Oct 13, 1987    May  CAHN
>A>   AP                                 0.25%;0.0091MG/ML                       N70966 001  Oct 13, 1987    May  CAHN
>A>   AP                                 0.5%;0.0091MG/ML                        N70968 001  Oct 13, 1987    May  CAHN
>A>   AP                                 0.5%;0.0091MG/ML                        N18304 004  Sep 02, 1983    May  CAHN
>A>   AP                                 0.75%;0.0091MG/ML                       N18304 005  Sep 02, 1983    May  CAHN
>D>   AP      ASTRAZENECA                0.25%;0.0091MG/ML                       N70967 001  Oct 13, 1987    May  CAHN
>D>   AP                                 0.25%;0.0091MG/ML                       N70966 001  Oct 13, 1987    May  CAHN
>D>   AP                                 0.5%;0.0091MG/ML                        N70968 001  Oct 13, 1987    May  CAHN
>D>   AP                                 0.5%;0.0091MG/ML                        N18304 004  Sep 02, 1983    May  CAHN
>D>   AP                                 0.75%;0.0091MG/ML                       N18304 005  Sep 02, 1983    May  CAHN
        CAFFEINE CITRATE
          SOLUTION; INTRAVENOUS
            CAFFEINE CITRATE
>A>   AP      LUITPOLD                   EQ 30MG BASE/3ML (EQ 10MG               N77906 001  May 15, 2007    May  NEWA

        CEFACLOR
          CAPSULE; ORAL
            CEFACLOR
>D>   AB      TEVA                       EQ 250MG BASE                           N64145 001  Jun 24, 1996    May  DISC
>A>         @                            EQ 250MG BASE                           N64145 001  Jun 24, 1996    May  DISC
>D>   AB                                 EQ 500MG BASE                           N64145 002  Jun 24, 1996    May  DISC
>A>         @                            EQ 500MG BASE                           N64145 002  Jun 24, 1996    May  DISC

        CEFADROXIL/CEFADROXIL HEMIHYDRATE
          CAPSULE; ORAL
            CEFADROXIL
>D>   AB      AUROBINDO                  500MG                                   N65352 001  Jan 25, 2007    May  CPOT
>A>   AB                                 EQ 500MG BASE                           N65352 001  Jan 25, 2007    May  CPOT
>A>   AB      LUPIN                      EQ 500MG BASE                           N65392 001  May 29, 2007    May  NEWA

        CEFAZOLIN SODIUM
          INJECTABLE; INJECTION
            CEFAZOLIN SODIUM
>A>   AP      SANDOZ                     EQ 1GM BASE/VIAL                        N65345 001  May 09, 2007    May  NEWA

        CEFDINIR
          CAPSULE; ORAL
            CEFDINIR
>A>   AB      TEVA PHARMS                300MG                                   N65368 001  May 09, 2007    May  NEWA

        CEFPROZIL
          TABLET; ORAL
            CEFPROZIL
>A>   AB      AUROBINDO                  250MG                                   N65340 001  May 24, 2007    May  NEWA
>A>   AB                                 500MG                                   N65340 002  May 24, 2007    May  NEWA

        CEPHALEXIN
          FOR SUSPENSION; ORAL
            CEPHALEXIN
>D>       +   CEPH INTL                  EQ 100MG BASE/ML                        N62117 001                  May  DISC
>A>         @                            EQ 100MG BASE/ML                        N62117 001                  May  DISC
>D>   AB      TEVA                       EQ 125MG BASE/5ML                       N62767 001  Jun 16, 1987    May  DISC
>A>         @                            EQ 125MG BASE/5ML                       N62767 001  Jun 16, 1987    May  DISC
>D>   AB                                 EQ 250MG BASE/5ML                       N62768 001  Jun 16, 1987    May  DISC
>A>         @                            EQ 250MG BASE/5ML                       N62768 001  Jun 16, 1987    May  DISC

>D>     CEPHRADINE
>D>       CAPSULE; ORAL
>D>         CEPHRADINE
>D>           TEVA                       250MG                                   N62683 001  Jan 09, 1987    May  DISC
>A>         @                            250MG                                   N62683 001  Jan 09, 1987    May  DISC
>D>       +                              500MG                                   N62683 002  Jan 09, 1987    May  DISC
>A>         @                            500MG                                   N62683 002  Jan 09, 1987    May  DISC
>D>       FOR SUSPENSION; ORAL
>D>         ANSPOR
>D>   AB      GLAXOSMITHKLINE            125MG/5ML                               N61866 001                  May  DISC
>A>         @                            125MG/5ML                               N61866 001                  May  DISC
>D>   AB                                 250MG/5ML                               N61866 002                  May  DISC
>A>         @                            250MG/5ML                               N61866 002                  May  DISC
>D>         CEPHRADINE
>D>   AB      TEVA                       125MG/5ML                               N62693 001  Jan 09, 1987    May  DISC
>A>         @                            125MG/5ML                               N62693 001  Jan 09, 1987    May  DISC
>D>   AB                                 250MG/5ML                               N62693 002  Jan 09, 1987    May  DISC
>A>         @                            250MG/5ML                               N62693 002  Jan 09, 1987    May  DISC
>D>         VELOSEF '125'
>D>   AB  +   APOTHECON                  125MG/5ML                               N61763 001                  May  DISC
>A>         @                            125MG/5ML                               N61763 001                  May  DISC
>D>         VELOSEF '250'
>D>   AB  +   APOTHECON                  250MG/5ML                               N61763 002                  May  DISC
>A>         @                            250MG/5ML                               N61763 002                  May  DISC

        CITALOPRAM HYDROBROMIDE
          TABLET; ORAL
            CITALOPRAM HYDROBROMIDE
>D>   AB      ROXANE                     EQ 10MG BASE                            N77041 001  Nov 23, 2004    May  DISC
>A>         @                            EQ 10MG BASE                            N77041 001  Nov 23, 2004    May  DISC
>D>   AB                                 EQ 20MG BASE                            N77041 002  Nov 23, 2004    May  DISC
>A>         @                            EQ 20MG BASE                            N77041 002  Nov 23, 2004    May  DISC

        CLINDAMYCIN PHOSPHATE
          INJECTABLE; INJECTION
            CLINDAMYCIN PHOSPHATE
>A>   AP      ABRAXIS PHARM              EQ 150MG BASE/ML                        N65347 001  May 09, 2007    May  NEWA

        CLOCORTOLONE PIVALATE
          CREAM; TOPICAL
            CLODERM
>A>       +   CORIA                      0.1%                                    N17765 001                  May  CAHN
>D>       +   HEALTHPOINT                0.1%                                    N17765 001                  May  CAHN

        CLOZAPINE
          TABLET, ORALLY DISINTEGRATING; ORAL
            FAZACLO ODT
>A>           AVANIR PHARMS              12.5MG                                  N21590 004  May 30, 2007    May  NEWA

        CROMOLYN SODIUM
          SOLUTION; INHALATION
            CROMOLYN SODIUM
>D>   AN      ROXANE                     10MG/ML                                 N75175 001  Sep 30, 1999    May  DISC
>A>         @                            10MG/ML                                 N75175 001  Sep 30, 1999    May  DISC

        DALTEPARIN SODIUM
>D>       INJECTABLE; INJECTION
>D>         FRAGMIN
>D>       +   PHARMACIA AND              2,500 IU/0.2ML                          N20287 001  Dec 22, 1994    May  CDFR
>D>       +                              5,000 IU/0.2ML                          N20287 003  Mar 18, 1996    May  CDFR
>D>       +                              7,500 IU/0.3ML                          N20287 005  Apr 04, 2002    May  CDFR
>D>       +                              10,000 IU/ML                            N20287 004  Jan 30, 1998    May  CDFR
>D>       +                              95,000IU/3.8ML(25,000IU/ML)             N20287 006  Apr 04, 2002    May  CDFR
>D>       +                              95,000IU/9.5ML(10,000IU/ML)             N20287 007  Apr 04, 2002    May  CDFR
>A>       INJECTABLE; SUBCUTANEOUS
>A>         FRAGMIN
>A>       +   PHARMACIA AND              2,500IU/0.2ML (12,500IU/ML)             N20287 001  Dec 22, 1994    May  CDFR
>A>       +                              5,000IU/0.2ML (25,000IU/ML)             N20287 003  Mar 18, 1996    May  CDFR
>A>       +                              7,500IU/0.3ML (25,000IU/ML)             N20287 005  Apr 04, 2002    May  CDFR
>A>       +                              10,000IU/0.4ML (25,000IU/ML)            N20287 002  May 01, 2007    May  NEWA
>A>       +                              10,000IU/ML (10,000IU/ML)               N20287 004  Jan 30, 1998    May  CDFR
>A>       +                              12,500IU/0.5ML (25,000IU/ML)            N20287 009  May 01, 2007    May  NEWA
>A>       +                              15,000IU/0.6ML (25,000IU/ML)            N20287 010  May 01, 2007    May  NEWA
>A>       +                              18,000IU/0.72ML (25,000IU/ML)           N20287 011  May 01, 2007    May  NEWA
>A>       +                              95,000IU/3.8ML(25,000IU/ML)             N20287 006  Apr 04, 2002    May  CDFR
>A>       +                              95,000IU/9.5ML(10,000IU/ML)             N20287 007  Apr 04, 2002    May  CDFR

        DAPSONE
          GEL; TOPICAL
            ACZONE
>A>         @ QLT USA                    5%                                      N21794 001  Jul 07, 2005    May  CAHN
>D>         @ TOLMAR                     5%                                      N21794 001  Jul 07, 2005    May  CAHN

        DEFEROXAMINE MESYLATE
          INJECTABLE; INJECTION
            DEFEROXAMINE MESYLATE
>A>   AP      BEDFORD                    500MG/VIAL                              N78086 001  May 30, 2007    May  NEWA
>A>   AP                                 2GM/VIAL                                N78086 002  May 30, 2007    May  NEWA

        DESONIDE
          CREAM; TOPICAL
>A>         DESONIDE
>A>   AB  +   PERRIGO NEW YORK           0.05%                                   N17010 001                  May  CTNA
>D>         TRIDESILON
>D>   AB  +   PERRIGO NEW YORK           0.05%                                   N17010 001                  May  CTNA
          OINTMENT; TOPICAL
>A>         DESONIDE
>A>   AB  +   PERRIGO NEW YORK           0.05%                                   N17426 001                  May  CTNA
>D>         TRIDESILON
>D>   AB  +   PERRIGO NEW YORK           0.05%                                   N17426 001                  May  CTNA

        DIAZOXIDE
          SUSPENSION; ORAL
            PROGLYCEM
>D>       +   BAKER NORTON               50MG/ML                                 N17453 001                  May  CAHN
>A>       +   IVAX RES                   50MG/ML                                 N17453 001                  May  CAHN

        DIFLORASONE DIACETATE
          OINTMENT; TOPICAL
>D>         FLORONE
>D>         @ PHARMACIA AND              0.05%                                   N17994 001                  May  CTNA
>A>         PSORCON E
>A>         @ PHARMACIA AND              0.05%                                   N17994 001                  May  CTNA

        ECONAZOLE NITRATE
          CREAM; TOPICAL
            ECONAZOLE NITRATE
>D>   AB      HEALTHPOINT                1%                                      N76574 001  Dec 17, 2004    May  CAHN
>A>   AB      PRASCO                     1%                                      N76574 001  Dec 17, 2004    May  CAHN

        ENALAPRILAT
          INJECTABLE; INJECTION
            VASOTEC
>D>         @ BIOVAIL LABS INTL          1.25MG/ML                               N19309 001  Feb 09, 1988    May  CMFD
>A>   AP  +                              1.25MG/ML                               N19309 001  Feb 09, 1988    May  CMFD

        ERYTHROMYCIN
          OINTMENT; TOPICAL
            AKNE-MYCIN
>A>       +   CORIA                      2%                                      N50584 001  Jan 10, 1985    May  CAHN
>D>       +   HEALTHPOINT                2%                                      N50584 001  Jan 10, 1985    May  CAHN
          SWAB; TOPICAL
>D>         C-SOLVE-2
>D>   AT      IVAX PHARMS                2%                                      N62751 001  Jul 30, 1993    May  DISC
>A>         @                            2%                                      N62751 001  Jul 30, 1993    May  DISC
>D>         ERYCETTE
>D>   AT  +   J AND J                    2%                                      N50594 001  Feb 15, 1985    May  DISC
>A>         @                            2%                                      N50594 001  Feb 15, 1985    May  DISC
            ERYTHROMYCIN
>D>   AT      ALTANA                     2%                                      N65320 001  Jul 25, 2006    May  CRLD
>A>   AT  +                              2%                                      N65320 001  Jul 25, 2006    May  CRLD
>D>   AT      STIEFEL                    2%                                      N64128 001  Jul 03, 1996    May  DISC
>A>         @                            2%                                      N64128 001  Jul 03, 1996    May  DISC
>D>   AT                                 2%                                      N64126 001  Jul 03, 1996    May  CRLD
>A>   AT  +                              2%                                      N64126 001  Jul 03, 1996    May  CRLD

        ESTAZOLAM
          TABLET; ORAL
            ESTAZOLAM
>D>   AB      TEVA                       2MG                                     N74921 002  Jul 10, 1997    May  CRLD
>A>   AB  +                              2MG                                     N74921 002  Jul 10, 1997    May  CRLD

        ETHINYL ESTRADIOL; LEVONORGESTREL
          TABLET; ORAL
>A>         LYBREL
>A>       +   WYETH PHARMS               0.02MG;0.09MG                           N21864 001  May 22, 2007    May  NEWA

        FLUOXETINE HYDROCHLORIDE
          CAPSULE; ORAL
            FLUOXETINE
>A>   AB      MYLAN                      EQ 40MG BASE                            N75207 003  May 25, 2007    May  NEWA

>A>     FORMOTEROL FUMARATE
>A>       SOLUTION; INHALATION
>A>         PERFOROMIST
>A>       +   DEY LP                     0.02MG/2ML                              N22007 001  May 11, 2007    May  NEWA

        GABAPENTIN
          CAPSULE; ORAL
            GABAPENTIN
>A>   AB      WATSON LABS                100MG                                   N75485 003  May 11, 2007    May  NEWA
>A>   AB                                 300MG                                   N75485 002  May 11, 2007    May  NEWA
>A>   AB                                 400MG                                   N75485 001  May 11, 2007    May  NEWA

        GEMFIBROZIL
          TABLET; ORAL
            GEMFIBROZIL
>A>   AB      IMPAX PHARMS               600MG                                   N78207 001  Jun 01, 2007    May  NEWA

        HISTRELIN ACETATE
          IMPLANT; SUBCUTANEOUS
>A>         SUPPRELIN LA
>A>       +   INDEVUS                    50MG                                    N22058 001  May 03, 2007    May  NEWA

        HYDROCORTISONE BUTYRATE
>A>       LOTION; TOPICAL
>A>         LOCOID
>A>       +   FERNDALE LABS              0.1%                                    N22076 001  May 18, 2007    May  NEWA

        IDARUBICIN HYDROCHLORIDE
          INJECTABLE; INJECTION
            IDARUBICIN HYDROCHLORIDE
>A>   AP      BEDFORD LABS               1MG/ML                                  N65288 001  May 15, 2007    May  NEWA

        INDIUM IN-111 CHLORIDE
          INJECTABLE; INJECTION
            INDICLOR
>D>       +   AMERSHAM                   2mCi/0.2ML                              N19862 001  Dec 29, 1992    May  CAHN
>A>       +   GE HEALTHCARE              2mCi/0.2ML                              N19862 001  Dec 29, 1992    May  CAHN

        INSULIN GLULISINE RECOMBINANT
>A>       INJECTABLE; IV (INFUSION)-SC
>A>         APIDRA
>A>       +   SANOFI AVENTIS US          1000 UNITS/10ML (100 UNITS/ML)          N21629 001  Apr 16, 2004    May  CDFR
>A>       +                              300 UNITS/3ML (100 UNITS/ML)            N21629 002  Dec 20, 2005    May  CDFR
>D>       INJECTABLE; SUBCUTANEOUS
>D>         APIDRA
>D>       +   SANOFI AVENTIS US          1000 UNITS/10ML (100 UNITS/ML)          N21629 001  Apr 16, 2004    May  CDFR
>D>       +                              300 UNITS/3ML (100 UNITS/ML)            N21629 002  Dec 20, 2005    May  CDFR

        LEUCOVORIN CALCIUM
          INJECTABLE; INJECTION
            LEUCOVORIN CALCIUM
>D>   AP      PHARMACHEMIE               EQ 350MG BASE/VIAL                      N40262 001  Dec 15, 1999    May  DISC
>A>         @                            EQ 350MG BASE/VIAL                      N40262 001  Dec 15, 1999    May  DISC
>D>   AP      PHARMACHEMIE USA           EQ 50MG BASE/VIAL                       N89628 001  Apr 17, 1997    May  DISC
>A>         @                            EQ 50MG BASE/VIAL                       N89628 001  Apr 17, 1997    May  DISC

>A>     LEVOCETIRIZINE DIHYDROCHLORIDE
>A>       TABLET; ORAL
>A>         XYZAL
>A>       +   UCB INC                    5MG                                     N22064 001  May 25, 2007    May  NEWA

        LISDEXAMFETAMINE DIMESYLATE
          CAPSULE; ORAL
            VYVANSE
>D>           NEW RIVER                  30MG                                    N21977 001  Feb 23, 2007    May  CAHN
>D>                                      50MG                                    N21977 002  Feb 23, 2007    May  CAHN
>D>       +                              70MG                                    N21977 003  Feb 23, 2007    May  CAHN
>A>           NEW RIVER                  30MG                                    N21977 001  Feb 23, 2007    May  CAHN
>A>                                      50MG                                    N21977 002  Feb 23, 2007    May  CAHN
>A>       +                              70MG                                    N21977 003  Feb 23, 2007    May  CAHN

        MAFENIDE ACETATE
          CREAM; TOPICAL
            SULFAMYLON
>D>       +   MYLAN BERTEK               EQ 85MG BASE/GM                         N16763 001                  May  CAHN
>A>       +   UDL LABS                   EQ 85MG BASE/GM                         N16763 001                  May  CAHN
          FOR SOLUTION; TOPICAL
            SULFAMYLON
>D>       +   MYLAN BERTEK               5%                                      N19832 003  Jun 05, 1998    May  CAHN
>A>       +   UDL LABS                   5%                                      N19832 003  Jun 05, 1998    May  CAHN

        MEPIVACAINE HYDROCHLORIDE
          INJECTABLE; INJECTION
            POLOCAINE
>A>   AP      ABRAXIS                    1%                                      N89407 001  Dec 01, 1986    May  CAHN
>A>   AP                                 2%                                      N89410 001  Dec 01, 1986    May  CAHN
>D>   AP      ASTRAZENECA                1%                                      N89407 001  Dec 01, 1986    May  CAHN
>D>   AP                                 2%                                      N89410 001  Dec 01, 1986    May  CAHN
            POLOCAINE-MPF
>A>   AP      ABRAXIS                    1%                                      N89406 001  Dec 01, 1986    May  CAHN
>A>   AP                                 1.5%                                    N89408 001  Dec 01, 1986    May  CAHN
>A>   AP                                 2%                                      N89409 001  Dec 01, 1986    May  CAHN
>D>   AP      ASTRAZENECA                1%                                      N89406 001  Dec 01, 1986    May  CAHN
>D>   AP                                 1.5%                                    N89408 001  Dec 01, 1986    May  CAHN
>D>   AP                                 2%                                      N89409 001  Dec 01, 1986    May  CAHN

>A>     MERCAPTOPURINE
>A>       TABLET; ORAL
>A>         MERCAPTOPURINE
>A>   AB      MYLAN                      50MG                                    N40594 001  Jul 01, 2005    May  CAIN

>D>     MERCAPTOPURINE ANHYDROUS
>D>       TABLET; ORAL
>D>         MERCAPTOPURINE
>D>   AB      MYLAN                      50MG                                    N40594 001  Jul 01, 2005    May  CAIN

>A>     METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
>A>       TABLET; ORAL
>A>         ACTOPLUS MET
>A>           TAKEDA GLOBAL              500MG;EQ 15MG BASE                      N21842 001  Aug 29, 2005    May  CAIN
>A>       +                              850MG;EQ 15MG BASE                      N21842 002  Aug 29, 2005    May  CAIN

>D>     METFORMIN; PIOGLITAZONE HYDROCHLORIDE
>D>       TABLET; ORAL
>D>         ACTOPLUS MET
>D>           TAKEDA GLOBAL              500MG;EQ 15MG BASE                      N21842 001  Aug 29, 2005    May  CAIN
>D>       +                              850MG;EQ 15MG BASE                      N21842 002  Aug 29, 2005    May  CAIN

        METHADONE HYDROCHLORIDE
          TABLET; ORAL
            METHADONE HYDROCHLORIDE
>D>   AA      ROXANE                     5MG                                     N88108 001  Mar 08, 1983    May  DISC
>A>         @                            5MG                                     N88108 001  Mar 08, 1983    May  DISC
>D>   AA                                 10MG                                    N88109 001  Mar 08, 1983    May  DISC
>A>         @                            10MG                                    N88109 001  Mar 08, 1983    May  DISC
>D>   AA                                 40MG                                    N74081 001  Apr 28, 1995    May  DISC
>A>         @                            40MG                                    N74081 001  Apr 28, 1995    May  DISC

        METHYLPHENIDATE HYDROCHLORIDE
          CAPSULE, EXTENDED RELEASE; ORAL
            METADATE CD
>D>   BX  +   UCB INC                    30MG                                    N21259 002  Jun 19, 2003    May  CRLD
>A>   BX                                 30MG                                    N21259 002  Jun 19, 2003    May  CRLD

        METOLAZONE
          TABLET; ORAL
            METOLAZONE
>D>   AB      ROXANE                     10MG                                    N76482 002  Apr 29, 2004    May  DISC
>A>         @                            10MG                                    N76482 002  Apr 29, 2004    May  DISC

        METOPROLOL SUCCINATE
          TABLET, EXTENDED RELEASE; ORAL
            METOPROLOL SUCCINATE
>A>   AB      KV PHARM                   EQ 100MG TARTRATE                       N76640 002  May 18, 2007    May  NEWA
>A>   AB                                 EQ 200MG TARTRATE                       N76640 001  May 18, 2007    May  NEWA
>A>   AB      SANDOZ                     EQ 50MG TARTRATE                        N76969 002  May 18, 2007    May  NEWA
            TOPROL-XL
>D>       +   ASTRAZENECA                EQ 50MG TARTRATE                        N19962 001  Jan 10, 1992    May  CFTG
>A>   AB  +                              EQ 50MG TARTRATE                        N19962 001  Jan 10, 1992    May  CFTG
>D>                                      EQ 100MG TARTRATE                       N19962 002  Jan 10, 1992    May  CFTG
>A>   AB                                 EQ 100MG TARTRATE                       N19962 002  Jan 10, 1992    May  CFTG
>D>       +                              EQ 200MG TARTRATE                       N19962 003  Jan 10, 1992    May  CFTG
>A>   AB  +                              EQ 200MG TARTRATE                       N19962 003  Jan 10, 1992    May  CFTG

        METOPROLOL TARTRATE
          INJECTABLE; INJECTION
            METOPROLOL TARTRATE
>A>   AP      HIKMA                      1MG/ML                                  N77761 001  May 30, 2007    May  NEWA

        MORPHINE SULFATE
          INJECTABLE; INJECTION
            ASTRAMORPH PF
>A>   AP      ABRAXIS                    0.5MG/ML                                N71051 001  Oct 07, 1986    May  CAHN
>A>   AP                                 0.5MG/ML                                N71050 001  Oct 07, 1986    May  CAHN
>A>   AP                                 1MG/ML                                  N71053 001  Oct 07, 1986    May  CAHN
>A>   AP                                 1MG/ML                                  N71052 001  Oct 07, 1986    May  CAHN
>D>   AP      ASTRAZENECA                0.5MG/ML                                N71051 001  Oct 07, 1986    May  CAHN
>D>   AP                                 0.5MG/ML                                N71050 001  Oct 07, 1986    May  CAHN
>D>   AP                                 1MG/ML                                  N71053 001  Oct 07, 1986    May  CAHN
>D>   AP                                 1MG/ML                                  N71052 001  Oct 07, 1986    May  CAHN

        OXYBUTYNIN CHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
            OXYBUTYNIN CHLORIDE
>A>   AB      IMPAX PHARMS               5MG                                     N76745 002  May 09, 2007    May  NEWA
>A>   AB                                 10MG                                    N76745 003  May 09, 2007    May  NEWA
>A>   AB      MYLAN                      15MG                                    N78293 001  May 10, 2007    May  NEWA

        OXYCODONE HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
            OXYCONTIN
>D>           PURDUE PHARMA LP           15MG                                    N20553 006  Sep 18, 2006    May  DISC
>A>         @                            15MG                                    N20553 006  Sep 18, 2006    May  DISC
>D>                                      30MG                                    N20553 007  Sep 18, 2006    May  DISC
>A>         @                            30MG                                    N20553 007  Sep 18, 2006    May  DISC
>D>                                      60MG                                    N20553 008  Sep 18, 2006    May  DISC
>A>         @                            60MG                                    N20553 008  Sep 18, 2006    May  DISC

        POLYETHYLENE GLYCOL 3350
          FOR SOLUTION; ORAL
            POLYETHYLENE GLYCOL 3350
>D>   AA      COASTAL PHARMS             17GM/SCOOPFUL                           N77893 001  May 26, 2006    May  CAHN
>A>   AA      PADDOCK                    17GM/SCOOPFUL                           N77893 001  May 26, 2006    May  CAHN

        POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
          FOR SUSPENSION; ORAL
            GO-EVAC
>A>   AA      BOCA PHARMA                236GM/BOT;2.97GM/BOT;6.74GM/BOT;        N73433 001  Apr 28, 1992    May  CAHN
>D>   AA      COPLEY PHARM               236GM/BOT;2.97GM/BOT;6.74GM/BOT;        N73433 001  Apr 28, 1992    May  CAHN

        PRAVASTATIN SODIUM
          TABLET; ORAL
            PRAVASTATIN SODIUM
>A>   AB      GLENMARK                   10MG                                    N77987 001  May 11, 2007    May  NEWA
>A>   AB                                 20MG                                    N77987 002  May 11, 2007    May  NEWA
>A>   AB                                 40MG                                    N77987 003  May 11, 2007    May  NEWA

        PROPRANOLOL HYDROCHLORIDE
>D>       CONCENTRATE; ORAL
>D>         PROPRANOLOL HYDROCHLORIDE INTENSOL
>D>       +   ROXANE                     80MG/ML                                 N71388 001  May 15, 1987    May  DISC
>A>         @                            80MG/ML                                 N71388 001  May 15, 1987    May  DISC

        QUETIAPINE FUMARATE
>A>       TABLET, EXTENDED RELEASE; ORAL
>A>         SEROQUEL XR
>A>           ASTRAZENECA                50MG                                    N22047 001  May 17, 2007    May  NEWA
>A>                                      200MG                                   N22047 002  May 17, 2007    May  NEWA
>A>                                      300MG                                   N22047 003  May 17, 2007    May  NEWA
>A>       +                              400MG                                   N22047 004  May 17, 2007    May  NEWA

>A>     ROTIGOTINE
>A>       FILM, EXTENDED RELEASE; TRANSDERMAL
>A>         NEUPRO
>A>           SCHWARZ                    2MG/24HR                                N21829 001  May 09, 2007    May  NEWA
>A>                                      4MG/24HR                                N21829 002  May 09, 2007    May  NEWA
>A>       +                              6MG/24HR                                N21829 003  May 09, 2007    May  NEWA

        SIMVASTATIN
          TABLET; ORAL
            SIMVASTATIN
>A>   AB      LUPIN                      10MG                                    N78103 001  May 11, 2007    May  NEWA
>A>   AB                                 20MG                                    N78103 002  May 11, 2007    May  NEWA
>A>   AB                                 40MG                                    N78103 003  May 11, 2007    May  NEWA
>A>   AB                                 80MG                                    N78103 004  May 11, 2007    May  NEWA

        TAMOXIFEN CITRATE
          TABLET; ORAL
            TAMOXIFEN CITRATE
>D>   AB      PHARMACHEMIE               EQ 20MG BASE                            N74858 001  Feb 20, 2003    May  CRLD
>A>   AB  +   TEVA PHARMS                EQ 20MG BASE                            N74858 001  Feb 20, 2003    May  CRLD

        TECHNETIUM TC-99M SESTAMIBI KIT
          INJECTABLE; INJECTION
>D>         MIRALUMA
>D>       +   BRISTOL MYERS              N/A                                     N19785 003  May 23, 1997    May  DISC
>A>         @                            N/A                                     N19785 003  May 23, 1997    May  DISC

>A>     TEMSIROLIMUS
>A>       SOLUTION; INTRAVENOUS
>A>         TORISEL
>A>       +   WYETH PHARMS               25MG/ML (25MG/ML)                       N22088 001  May 30, 2007    May  NEWA

        TESTOSTERONE
          GEL; TRANSDERMAL
            TESTOSTERONE
>A>   AB      PAR PHARM                  1%                                      N76744 001  May 23, 2007    May  NEWA

        TETRACYCLINE HYDROCHLORIDE
          FIBER, EXTENDED RELEASE; PERIODONTAL
            ACTISITE
>D>         @ ALZA                       12.7MG/FIBER                            N50653 001  Mar 25, 1994    May  CAHN
>A>         @ ON SITE                    12.7MG/FIBER                            N50653 001  Mar 25, 1994    May  CAHN

        THIORIDAZINE HYDROCHLORIDE
          CONCENTRATE; ORAL
>D>         THIORIDAZINE HYDROCHLORIDE INTENSOL
>D>   AA      ROXANE                     30MG/ML                                 N88941 001  Dec 16, 1985    May  DISC
>A>         @                            30MG/ML                                 N88941 001  Dec 16, 1985    May  DISC
>D>   AA                                 100MG/ML                                N88942 001  Dec 16, 1985    May  DISC
>A>         @                            100MG/ML                                N88942 001  Dec 16, 1985    May  DISC

        TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
            TARKA
>D>       +   ABBOTT                     1MG;240MG                               N20591 003  Oct 22, 1996    May  CRLD
>A>                                      1MG;240MG                               N20591 003  Oct 22, 1996    May  CRLD
>D>       +                              2MG;180MG                               N20591 001  Oct 22, 1996    May  CRLD
>A>                                      2MG;180MG                               N20591 001  Oct 22, 1996    May  CRLD
>D>       +                              2MG;240MG                               N20591 004  Oct 22, 1996    May  CRLD
>A>                                      2MG;240MG                               N20591 004  Oct 22, 1996    May  CRLD

        VERAPAMIL HYDROCHLORIDE
          CAPSULE, EXTENDED RELEASE; ORAL
            VERELAN
>D>   AB  +   ELAN DRUG                  120MG                                   N19614 001  May 29, 1990    May  CRLD
>A>   AB                                 120MG                                   N19614 001  May 29, 1990    May  CRLD
>D>   AB  +                              180MG                                   N19614 003  Jan 09, 1992    May  CRLD
>A>   AB                                 180MG                                   N19614 003  Jan 09, 1992    May  CRLD
>D>   AB  +                              240MG                                   N19614 002  May 29, 1990    May  CRLD
>A>   AB                                 240MG                                   N19614 002  May 29, 1990    May  CRLD

        ZICONOTIDE
          INJECTABLE; INTRATHECAL
            PRIALT
>D>       +   ELAN PHARMS                100UGM/1ML(100MG/ML)                    N21060 002  Dec 28, 2004    May  CPOT
>A>       +                              100UGM/1ML(100UGM/ML)                   N21060 002  Dec 28, 2004    May  CPOT
>D>       +                              500UGM/20ML(25MG/ML)                    N21060 001  Dec 28, 2004    May  CPOT
>A>       +                              500UGM/20ML(25UGM/ML)                   N21060 001  Dec 28, 2004    May  CPOT
>D>       +                              500UGM/5ML(100MG/ML)                    N21060 004  Dec 28, 2004    May  CPOT
>A>       +                              500UGM/5ML(100UGM/ML)                   N21060 004  Dec 28, 2004    May  CPOT

        ZIDOVUDINE
          CAPSULE; ORAL
            ZIDOVUDINE
>A>   AB      CIPLA LTD                  100MG                                   N78349 001  May 23, 2007    May  NEWA

        ZILEUTON
>A>       TABLET, EXTENDED RELEASE; ORAL
>A>         ZYFLO CR
>A>       +   CRITICAL                   600MG                                   N22052 001  May 30, 2007    May  NEWA

        ZOLPIDEM TARTRATE
          TABLET; ORAL
            ZOLPIDEM TARTRATE
>A>   AB      WOCKHARDT                  5MG                                     N78426 001  May 15, 2007    May  NEWA
>A>   AB                                 10MG                                    N78426 002  May 15, 2007    May  NEWA



ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

     BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
            EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
>D>       +   ALZA                       16MG;240MG                              N19672 001  Mar 29, 1996    May  DISC
>A>         @                            16MG;240MG                              N19672 001  Mar 29, 1996    May  DISC

        NICOTINE POLACRILEX
          GUM, CHEWING; BUCCAL
            NICOTINE POLACRILEX
>A>           PERRIGO R AND D            EQ 2MG BASE                             N78547 001  May 24, 2007    May  NEWA
>A>                                      EQ 4MG BASE                             N78546 001  May 24, 2007    May  NEWA

        PSEUDOEPHEDRINE HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
>D>         EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE
>D>       +   ALZA                       240MG                                   N20021 002  Dec 15, 1992    May  CTNA
>A>         SUDAFED 24 HOUR
>A>       +   ALZA                       240MG                                   N20021 002  Dec 15, 1992    May  CTNA

 

 
-